for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Scopus Biopharma Inc

SCPS.OQ

Latest Trade

7.79USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

5.44

 - 

47.85

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
7.79
Open
--
Volume
--
3M AVG Volume
3.25
Today's High
--
Today's Low
--
52 Week High
47.85
52 Week Low
5.44
Shares Out (MIL)
15.73
Market Cap (MIL)
122.99
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Scopus Biopharma Announces Pricing Of Initial Public Offering

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Scopus Biopharma Inc

Scopus BioPharma Inc. is a biotechnology company. The Company is focused on developing therapeutics targeting serious diseases. The Company’s lead program targets immuno-oncology gene therapy for the treatment of multiple cancers. Its lead development program is CpG-STAT3siRNA (CO-sTiRNA), which is in Phase I clinical trial, is a STAT3 inhibitor gene therapy. CO-sTiRNA is developed for the treatment of B-cell non-Hodgkins lymphoma. It also stimulates TLR9 receptors to activate the body’s immune defense to kill cancer cells. Its second development program is in pre-clinical stage MRI-1867, a cannabinoid receptor mediating compound for the treatment of systemic sclerosis. MRI-1867 is a small molecule that is an inverse agonist of the cannabinoid-1 receptor (CB1), as well as an inhibitor of the inducible nitric oxide synthase (iNOS) system.

Industry

Biotechnology & Drugs

Contact Info

420 Lexington Ave Rm 300

NEW YORK, NY

10170-0399

United States

+1.212.4792513

Key Stats

2.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2020

0.0K

2021(E)

0.0K
EPS (USD)

2020

-0.810

2021(E)

-0.410
Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
-791.21

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up